Volume 9, Issue 3, September 2020, Page: 89-93
The Value of Predictive Nursing in Perioperative Period of Allogeneic Hematopoietic Stem Cell Transplantation
Yun Pan, Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, China
Dongdong Chen, Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, China
Received: Sep. 3, 2020;       Accepted: Sep. 15, 2020;       Published: Sep. 28, 2020
DOI: 10.11648/j.sjcm.20200903.17      View  214      Downloads  76
Abstract
Background: Predictive nursing is a new concept proposed in recent years. Studies have shown that predictive care is effective in critically ill and surgical patients. However, the application and research of predictive nursing in patients with allogeneic hematopoietic stem cell transplantation (allo-HSCT) during perioperative period is still lacking. Objective: The value and clinical effect of predictive nursing in allo-HSCT during the perioperative period. Methods: Retrospective analysis was performed on 36 patients with hematological disease who had received allo-HSCT. Observation group A was the patient who received oral care, perineal care and perianal care during the transplantation period; group B was the patient who received only one of the three care items; group C was the patient who received no nursing intervention. And then the time of stem cell transplantation, the incidence of infection, and the cost of treatment were analyzed among the three groups. Results: Predictive nursing intervention can significantly shorten the transplantation time of granulocytes and megakaryocytes (A vs. C, P=0.000, P=0.000; B vs. C, P=0.000, P=0.000). Patients receiving oral care, perineal care and perianal care at the same time had a tendency to shorten the transplant time of stem cells and effectively reduce the incidence of respiratory and urinary tract infections compared with patients receiving only one nursing intervention (X2=5.538, X2=5.924; P=0.019, P=0.05). And reduce the cost of treatment during transplantation (A vs. C, P=0.006). Conclusions: In the perioperative period of allogeneic hematopoietic stem cells, various predictive nursing interventions can shorten the transplantation time of stem cells, reduce the incidence of infection, and thus reduce the economic burden of patients. It is a cheap and effective method and worthy of clinical application.
Keywords
Predictive Nursing, Allogeneic Hematopoietic Stem Cell Transplantation, Transplantation Time
To cite this article
Yun Pan, Dongdong Chen, The Value of Predictive Nursing in Perioperative Period of Allogeneic Hematopoietic Stem Cell Transplantation, Science Journal of Clinical Medicine. Vol. 9, No. 3, 2020, pp. 89-93. doi: 10.11648/j.sjcm.20200903.17
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Wang QY, Dong YJ, Liang ZY, Yin Y, Liu W, Xu WL, et al. [Clinical Analysis for Patients with AML Treated after Allo-HSCT]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020; 28 (4): 1105-1114.
[2]
Zhu Y, Gao Q, Hu J, Liu X, Guan D, Zhang F. Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis. BMC Immunol. 2020; 21 (1): 10.
[3]
Wang YF, Huang SY, Zhang ZH, Dong F, Wang Y, Jing HM, et al. [Clinical Efficacy of Allo-HSCT on FLT3-ITD Positive AML Patients]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020; 28 (4): 1183-1188.
[4]
Heath LJ, Delate T, Weffald L, Paulson DC, Sanchez JK, Herner SJ. A Predictive Model to Identify Skilled Nursing Facility Residents for Pharmacist Intervention. Consult Pharm. 2018; 33 (9): 504-520.
[5]
Meehan E, Foley T, Kelly C, Burgess Kelleher A, Sweeney C, Hally RM, et al. Advance Care Planning for Individuals With Chronic Obstructive Pulmonary Disease: A Scoping Review of the Literature. J Pain Symptom Manage. 2020; 59 (6): 1344-1361.
[6]
Sturgess DJ, Greenland KB, Senthuran S, Ajvadi FA, van Zundert A, Irwin MG. Tracheal extubation of the adult intensive care patient with a predicted difficult airway - a narrative review. Anaesthesia. 2017; 72 (2): 248-261.
[7]
Morris EC, Albert MH. Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies. Front Pediatr. 2019; 7: 437.
[8]
Girmenia C, Bertaina A, Piciocchi A, Perruccio K, Algarotti A, Busca A, et al. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey. Clin Infect Dis. 2017; 65 (11): 1884-1896.
[9]
Lee SE, Lim JY, Ryu DB, Kim TW, Park SS, Jeon YW, et al. Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2019; 25 (10): 1933-1943.
[10]
Barrett M, Boyne J, Brandts J, Brunner-La Rocca HP, De Maesschalck L, De Wit K, et al. Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care. EPMA J. 2019; 10 (4): 445-464.
[11]
Staffas A, van den Brink M. The intestinal flora is required for post-transplant hematopoiesis in recipients of a hematopoietic stem cell transplantation. Bone Marrow Transplant. 2019; 54 (Suppl 2): 756-758.
[12]
Hagan T, Cortese M, Rouphael N, Boudreau C, Linde C, Maddur MS, et al. Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans. Cell. 2019; 178 (6): 1313-1328 e1313.
[13]
Chen D, Wu J, Jin D, Wang B, Cao H. Fecal microbiota transplantation in cancer management: Current status and perspectives. Int J Cancer. 2019; 145 (8): 2021-2031.
[14]
Chauhan A, Gruenberg J, Arbefeville S, Mettler T, Brent CH, Ferrieri P. Disseminated Hormographiella aspergillata Infection with Lung and Brain Involvement after Allogenic Hematopoietic Stem-Cell Transplantation in a 54-Year-Old Man. Lab Med. 2019; 50 (4): 426-431.
Browse journals by subject